The present disclosure relates to a blood collection device, including: a shell; a blade seat, arranged in the shell; an elastic component for providing an elastic force for pivoting the blade seat; a triggering portion, including an operating end and an abutting end, wherein the triggering portion has a first position and a second position for pivoting, the operating end extends to the outside of the shell, the abutting end is located in the shell, based on the operation of the operating end, the triggering portion is suitable for pivoting from the first position that prevents the blade seat from pivoting to the second position that allows the blade seat to pivot based on the elastic force of the elastic component, wherein: a cooperation column is arranged in the shell and is located at the upper side of the triggering portion spaced from the triggering portion; and an elastic arm is connected to the upper side of the triggering portion, the end part of the elastic arm includes a blocking portion, the end part of the elastic arm is suitable for being located on one side of the cooperation column when the triggering portion is at the first position, and is located on the other side of the cooperation column when the triggering portion pivots from the first position to the second position, and the blocking portion provides resistance for the end part of the elastic arm while moving from one side of the cooperation column to the other side.

A patient table adapted for use in association with an MR scanner for neonatal infants is provided. The patient table has an extendable patient bed attached to and extendable from the patient table. The patient bed may be at least partially inserted into an MR scanner without requiring the patient table to enter the MR scanner. A transport mechanism is on the underside of the patient table so that it may be readily moved over the floor on which it rests. The patient table includes a latching mechanism that may operate to releasably attach the patient table to a patient table docking assembly. The docking assembly is operative to selectively move the patient table towards, into and away from the MR scanner.

There is provided an apparatus comprising a control unit and a method of operating the apparatus to determine a health status of an infant. The method comprises acquiring contextual information associated with the infant (302) and acquiring at least one heart rate variability signal from the infant (304). The at least one heart rate variability signal acquired from the infant is processed to determine a heart rate variability feature (306) and the determined heart rate variability feature is assigned to a class according to the acquired contextual information (308). The determined heart rate variability feature is compared to one or more corresponding heart rate variability features stored in the same class as the determined heart rate variability in a memory (310) and a health status of the infant is determined based on the comparison (312).

Systems and methods for detecting a motor developmental delay and/or neurodevelopmental disorder of an infant are described herein. An example method can include receiving motion data associated with the infant's gross motor activity; analyzing, using a machine learning algorithm, the motion data to detect a kinematic feature; comparing the kinematic feature to an expected relationship between the kinematic feature and infant age; and detecting the neurodevelopmental disorder based on the comparison. An infant sensor suit is also described herein. An example infant sensor suit can include an article of clothing; a plurality of sensors; a power source operably coupled to the sensors; and a wireless transmitter operably coupled to the sensors. The sensors, power source, and wireless transmitter can be incorporated into the article of clothing.

A system and method of displaying neonatal health information are disclosed. In one aspect, the method includes receiving data characterizing a start of an APGAR timer; receiving a time value associated with a current time of the APGAR timer; receiving and displaying on an electronic display a plurality of time windows and a corresponding plurality of target values, each of the plurality of target values representing a predetermined blood oxygen threshold value in connection with a corresponding one of the plurality of time windows; receiving and displaying on an electronic display a measured blood oxygen level value; and highlighting, on the electronic display, a first of the plurality of target values and a corresponding first of the plurality of time windows when the time value associated with the current time of the APGAR timer reaches a first time value.

A point-of-birth system and instrument, biochemical cartridge, and methods for newborn screening is disclosed. Namely, a point-of-birth system is provided that includes a point-of-birth instrument for receiving and processing a biochemical cartridge for performing newborn screening. Further, a portable smart device, such as a smartphone or tablet, is in communication with point-of-birth instrument, wherein the smart device may include a newborn screening (NBS) mobile app. In one example, the point-of-birth system and point-of-birth instrument support newborn biological screening only. However, in another example, the point-of-birth system and point-of-birth instrument support both newborn biological screening and newborn physiological screening.

The present invention relates to a method of identifying or monitoring circulatory failure in a subject, which method comprises assessing the subject's microcirculation in respect of the following parameters: (a) functional capillary density (FCD); (b) heterogeneity of the FCD; (c) capillary flow velocity; (d) heterogeneity of capillary flow velocity; (e) oxygen saturation of microvascular erythrocytes (SmvO.sub.2); and (f) heterogeneity of SmvO.sub.2; wherein parameters (a) to (d) are assessed visually by microscopy and parameters (e) and (f) are assessed by diffuse reflectance spectroscopy (DRS); well as apparatus and software designed for performance of such a method.

The invention relates to a device for measuring the concentration of an analyte in the blood or tissue of a an animal or a human, particularly a premature infant, wherein for measuring said concentration the device comprises a means (30) comprising at least a first and a second permeability with respect to said analyte, wherein the first permeability for said analyte differs from the second permeability for the analyte. Further, the invention relates to a corresponding method.

The present disclosure relates to a transfer table assembly and cart apparatus suitable for use in association with an MR scanner. The transfer table assembly may include a transfer table base and a supporting mechanism coupling the transfer table base to a transfer table cart in a cantilevered fashion at substantially the same level of a scanning bore of an MR scanner. The transfer table cart may include a frame designed to dock with the MR scanner.

Apparatus configured to detect congenital heart disease (CHD) in newborns may comprise a body with a cavity configured to receive a hand or foot of a newborn. Sensor pairs of the apparatus may be configured scan such that the best signals can be selected, which can accommodate for movements of the newborn and/or facilitate impartialness as to which body part is inserted in the apparatus. Positions of the sensor pairs may be adjusted to ensure contact with the newborn's skin. A disposable cover may protect the newborn's skin from contacting the apparatus. The apparatus may include a pressure device so that CHD threshold values can be adjusted for different altitudes. The apparatus may integrate with electronic medical record (EMR) systems.